Bank of New York Mellon’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.22M Sell
110,546
-6,953
-6% -$76.7K ﹤0.01% 3007
2025
Q1
$1.05M Buy
117,499
+1,720
+1% +$15.4K ﹤0.01% 3024
2024
Q4
$1.09M Sell
115,779
-5,282
-4% -$49.7K ﹤0.01% 3089
2024
Q3
$976K Sell
121,061
-29,911
-20% -$241K ﹤0.01% 3139
2024
Q2
$1.28M Sell
150,972
-11,056
-7% -$93.8K ﹤0.01% 3050
2024
Q1
$1.45M Sell
162,028
-34,356
-17% -$308K ﹤0.01% 2943
2023
Q4
$2.21M Sell
196,384
-6,929
-3% -$77.9K ﹤0.01% 2779
2023
Q3
$1.75M Sell
203,313
-12,840
-6% -$111K ﹤0.01% 2884
2023
Q2
$2.24M Buy
216,153
+6,139
+3% +$63.5K ﹤0.01% 2768
2023
Q1
$2.28M Sell
210,014
-1,582
-0.7% -$17.2K ﹤0.01% 2723
2022
Q4
$2.37M Buy
211,596
+6,126
+3% +$68.7K ﹤0.01% 2756
2022
Q3
$2.08M Buy
205,470
+23,555
+13% +$239K ﹤0.01% 2820
2022
Q2
$1.65M Sell
181,915
-7,782
-4% -$70.5K ﹤0.01% 2942
2022
Q1
$1.81M Buy
189,697
+1,371
+0.7% +$13.1K ﹤0.01% 2984
2021
Q4
$2.08M Buy
188,326
+11,905
+7% +$131K ﹤0.01% 2970
2021
Q3
$1.31M Buy
176,421
+1,062
+0.6% +$7.86K ﹤0.01% 3240
2021
Q2
$2.55M Sell
175,359
-26,950
-13% -$391K ﹤0.01% 2840
2021
Q1
$4.13M Sell
202,309
-3,771
-2% -$77K ﹤0.01% 2529
2020
Q4
$3.66M Sell
206,080
-4,895
-2% -$87K ﹤0.01% 2507
2020
Q3
$3.12M Sell
210,975
-4,340
-2% -$64.2K ﹤0.01% 2437
2020
Q2
$4.52M Buy
215,315
+4,347
+2% +$91.2K ﹤0.01% 2251
2020
Q1
$4.88M Buy
210,968
+7,600
+4% +$176K ﹤0.01% 2092
2019
Q4
$5.27M Buy
203,368
+6,097
+3% +$158K ﹤0.01% 2320
2019
Q3
$3.84M Sell
197,271
-10,572
-5% -$206K ﹤0.01% 2406
2019
Q2
$3.39M Sell
207,843
-1,366
-0.7% -$22.3K ﹤0.01% 2521
2019
Q1
$4.74M Buy
209,209
+1,092
+0.5% +$24.8K ﹤0.01% 2355
2018
Q4
$5.33M Buy
208,117
+2,547
+1% +$65.2K ﹤0.01% 2249
2018
Q3
$6.72M Sell
205,570
-520
-0.3% -$17K ﹤0.01% 2255
2018
Q2
$4.67M Sell
206,090
-3,817
-2% -$86.6K ﹤0.01% 2427
2018
Q1
$5.09M Sell
209,907
-774
-0.4% -$18.8K ﹤0.01% 2343
2017
Q4
$5.88M Buy
210,681
+350
+0.2% +$9.76K ﹤0.01% 2276
2017
Q3
$7.2M Buy
210,331
+2,624
+1% +$89.8K ﹤0.01% 2164
2017
Q2
$8.27M Buy
207,707
+1,684
+0.8% +$67.1K ﹤0.01% 2077
2017
Q1
$7.59M Buy
206,023
+5,188
+3% +$191K ﹤0.01% 2101
2016
Q4
$6.4M Sell
200,835
-21,009
-9% -$670K ﹤0.01% 2187
2016
Q3
$8.04M Buy
221,844
+42,075
+23% +$1.52M ﹤0.01% 1980
2016
Q2
$4.08M Buy
179,769
+36,397
+25% +$826K ﹤0.01% 2318
2016
Q1
$2.7M Buy
143,372
+2,752
+2% +$51.7K ﹤0.01% 2485
2015
Q4
$2.31M Buy
140,620
+12,004
+9% +$197K ﹤0.01% 2629
2015
Q3
$1.41M Sell
128,616
-735
-0.6% -$8.08K ﹤0.01% 2946
2015
Q2
$1.68M Buy
129,351
+10,357
+9% +$135K ﹤0.01% 3033
2015
Q1
$2.06M Buy
118,994
+2,486
+2% +$43.1K ﹤0.01% 2841
2014
Q4
$1.74M Sell
116,508
-3,989
-3% -$59.5K ﹤0.01% 2956
2014
Q3
$2.78M Buy
120,497
+372
+0.3% +$8.57K ﹤0.01% 2650
2014
Q2
$3.83M Buy
+120,125
New +$3.83M ﹤0.01% 2480